Keuer Thomas A 4
4 · ARCA biopharma, Inc. · Filed Mar 1, 2018
Insider Transaction Report
Form 4
Keuer Thomas A
Chief Operating Officer
Transactions
- Sale
Common Stock
2018-02-28$0.72/sh−410$294→ 13,635 total
Footnotes (3)
- [F1]Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Amended and Restated Equity Incentive Plan (the "Plan").
- [F2]The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.7111 to $0.723. Upon request of the SEC staff, ARCA biopharma, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased at each separate price.
- [F3]Includes remaining 1,207 previously reported shares issued as RSUs under the Plan that vest on 4/2/18, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan; and 12,428 previously reported shares of common stock owned.